Lv1
16 积分 2025-11-19 加入
Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma
1天前
待确认
Extramedullary disease but not paraskeletal disease portends inferior outcomes after CAR T cell therapy in multiple myeloma
15天前
已完结
Linperlisib Plus Chidamide in Relapsed or Refractory Cutaneous T-Cell Lymphoma
19天前
已完结
Incidence of enteropathy - associated T-cell lymphoma: A nation-wide study of a population-based registry in The Netherlands
19天前
已完结
Autologous CD19/BCMA CAR-T cell therapy for myasthenia gravis: Advancing care for those with severe disease
25天前
已完结
Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy
1个月前
已完结
Irreversible parkinsonism after idecabtagene vicleucel: long-term outcome of a rare BCMA CAR T-cell neurotoxicity
1个月前
已完结
Multiple Myeloma and Mimicry: Gastrointestinal Tract Histologic Findings in Patients Following Chimeric Antigen Receptor T-cell Therapy and Anti-CD38 Monoclonal Antibodiesx
1个月前
已关闭
Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction–associated steatohepatitis
1个月前
已完结
Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy
1个月前
已完结
皖公网安备34019202002308
